Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

about

Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity.Proteomic analysis identifies highly expressed plasma membrane proteins for detection and therapeutic targeting of specific breast cancer subtypes

P2860

Q47110103-FCA6B2C4-1310-4E26-A9DF-F2B1A6491363 Q58720701-94C206FC-B97B-4CFD-9317-6B33A09FC608

P2860

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

Item

http://www.wikidata.org/entity/Q49244460

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@en

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@nl

type

Item

label

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@en

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@nl

prefLabel

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@en

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@nl

P1476

Clinical and therapeutic relev ...... nthase in HER2+ breast cancer.

@en

P2093

Bruna Corominas-Faja

http://www.w3.org/2001/XMLSchema#string

Dolors Serra

http://www.w3.org/2001/XMLSchema#string

Jordi García

http://www.w3.org/2001/XMLSchema#string

Luciano Vellon

http://www.w3.org/2001/XMLSchema#string

Maria Buxó

http://www.w3.org/2001/XMLSchema#string

Ruth Lupu

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells

Metabolic control of cancer cell stemness: Lessons from iPS cells

Fatty acid synthase: a metabolic oncogene in prostate cancer?

Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis

Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?

Novel effect of C75 on carnitine palmitoyltransferase I activity and palmitate oxidation.

Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.

Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.

Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells.

P304

687-698

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.14670/HH-11-830

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elisabet Cuyàs

Javier A Menendez

Begoña Martin-Castillo

P577

2016-10-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27714708

http://www.w3.org/2001/XMLSchema#string

P921

fatty acid

P932

5784426

http://www.w3.org/2001/XMLSchema#string

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

about

P2860

P2860

Clinical and therapeutic relevance of the metabolic oncogene fatty acid synthase in HER2+ breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932